Enhanced alpha-adrenoceptor-mediated vasoconstriction contributes to increased vascular resistance in essential hypertension.
D004837:Epinephrine / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D009599:Nitroprusside / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D013569:Synapses; D014655:Vascular Resistance / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects; D015016:Yohimbine / Q000494:pharmacology
D011942:Receptors, Adrenergic, alpha; D009599:Nitroprusside; D015016:Yohimbine; D011224:Prazosin; D004837:Epinephrine